Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Day One Biopharmaceuticals (DAWN) Gross Profit: 2024

Historic Gross Profit for Day One Biopharmaceuticals (DAWN) over the last 1 years, with Dec 2024 value amounting to $131.2 million.

  • Day One Biopharmaceuticals' Gross Profit fell 57.56% to $39.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $133.7 million, marking a year-over-year change of. This contributed to the annual value of $131.2 million for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, Day One Biopharmaceuticals' Gross Profit is $131.2 million.
  • Day One Biopharmaceuticals' Gross Profit's 5-year high stood at $131.2 million during FY2024, with a 5-year trough of $131.2 million in FY2024.
  • Its 1-year average for Gross Profit is $131.2 million, with a median of $131.2 million in 2024.